Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer.
Woohyung LeeYe Jong ParkJae Woo KwonEunsung JunKi Byung SongJae Hoon LeeDae Wook HwangChanghoon YooKyu-Pyo KimJae Ho JeongHeung-Moon ChangBaek-Yeol RyooSeo Young ParkSong Cheol KimPublished in: Journal of clinical medicine (2020)
RDC was independently associated with better prognosis after NACT in patients with BRPC or LAPC. Decreased CA19-9 after NACT was a prognostic indicator of better survival and recurrence, as was normalization of CA 19-9 after both NACT and surgery.
Keyphrases
- locally advanced
- neoadjuvant chemotherapy
- rectal cancer
- squamous cell carcinoma
- radiation therapy
- phase ii study
- sentinel lymph node
- minimally invasive
- free survival
- lymph node
- coronary artery bypass
- protein kinase
- clinical trial
- surgical site infection
- coronary artery disease
- acute coronary syndrome
- liver metastases